End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
118 IDR | -7.09% | -4.07% | -89.69% |
May. 10 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
Mar. 15 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 715B 44.36M | Sales 2023 | 702B 43.53M | Capitalization | 613B 37.99M |
---|---|---|---|---|---|
Net income 2022 | 275B 17.08M | Net income 2023 | -85.22B -5.28M | EV / Sales 2022 | 1.73 x |
Net Debt 2022 | 773B 47.95M | Net Debt 2023 | 897B 55.62M | EV / Sales 2023 | 2.15 x |
P/E ratio 2022 |
1.68
x | P/E ratio 2023 |
-7.19
x | Employees | 1,193 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.08% |
1 day | -7.09% | ||
1 week | -4.07% | ||
1 month | +22.92% | ||
3 months | -85.34% | ||
6 months | -90.56% | ||
Current year | -89.69% |
Managers | Title | Age | Since |
---|---|---|---|
Yan Gwan Lee
CEO | Chief Executive Officer | 61 | 20-08-13 |
Yenfrino Gunadi
DFI | Director of Finance/CFO | 38 | 20-08-13 |
Bedjo Stefanus
PRN | Corporate Officer/Principal | 60 | 23-06-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 15-05-24 | |
Robby Yulianto
CHM | Chairman | 42 | 20-08-13 |
Director/Board Member | 65 | 22-03-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 118 | -7.09% | 82,261,000 |
24-05-30 | 127 | -3.79% | 85,601,400 |
24-05-29 | 132 | +6.45% | 136,051,200 |
24-05-28 | 124 | +4.20% | 75,644,400 |
End-of-day quote INDONESIA S.E., May 30, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-89.69% | 81.62M | |
+40.73% | 739B | |
+31.70% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.47% | 240B | |
+9.19% | 210B | |
-5.32% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- PYFA Stock